Danaher Corporation $DHR Stock Sold by River Street Advisors LLC

River Street Advisors LLC decreased its position in Danaher Corporation (NYSE:DHR) by 75.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 960 shares of the conglomerate’s stock after selling 3,011 shares during the quarter. River Street Advisors LLC’s holdings in Danaher were worth $213,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in DHR. Main Street Group LTD acquired a new stake in shares of Danaher during the first quarter worth $25,000. N.E.W. Advisory Services LLC acquired a new position in shares of Danaher in the 2nd quarter valued at about $25,000. Marquette Asset Management LLC boosted its holdings in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after buying an additional 73 shares during the period. Evolution Wealth Management Inc. boosted its holdings in shares of Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after buying an additional 104 shares during the period. Finally, Field & Main Bank bought a new stake in shares of Danaher during the 2nd quarter valued at about $29,000. Institutional investors own 79.05% of the company’s stock.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Robert W. Baird increased their price objective on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research note on Thursday. UBS Group restated a “buy” rating and issued a $260.00 target price on shares of Danaher in a research note on Thursday. Royal Bank Of Canada upped their target price on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Stifel Nicolaus increased their price target on Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. raised their price target on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $242.91.

Danaher Stock Performance

Danaher stock traded up $0.61 during mid-day trading on Friday, hitting $230.36. 3,935,897 shares of the company’s stock traded hands, compared to its average volume of 4,912,513. The company has a quick ratio of 1.25, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a 50 day moving average price of $216.32 and a 200 day moving average price of $197.35. The company has a market cap of $161.94 billion, a PE ratio of 37.70, a price-to-earnings-growth ratio of 2.87 and a beta of 0.76.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period last year, the company earned $1.89 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is currently 26.19%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.